Literature DB >> 11862181

Resolution of patch-type granuloma annulare lesions after biopsy.

Nikki A Levin1, James W Patterson, Luke L Yao, Barbara B Wilson.   

Abstract

We describe a patient with patch-type granuloma annulare whose lesions resolved after biopsy on 2 occasions. The lesions not subjected to biopsy persisted. There is a paucity of literature on the relation between biopsy and resolution of granuloma annulare, with one frequently cited article implying that biopsy is not related to resolution. We briefly consider possible mechanisms through which involution of lesions of granuloma annulare could result after biopsy or other form of trauma.

Entities:  

Mesh:

Year:  2002        PMID: 11862181     DOI: 10.1067/mjd.2002.118344

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  Case for diagnosis. Patch granuloma annulare.

Authors:  Geraldo Magela Magalhães; Cássio Ferreira Guimarães; Maysa Carla de Paula
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

2.  Remote Reverse Koebner Phenomenon in Atypical Granuloma Annulare.

Authors:  Bhanwar L Masuria; Girish C Baniya; Shraddha Galgali
Journal:  Indian J Dermatol       Date:  2021 Sep-Oct       Impact factor: 1.494

3.  Remote reverse Koebner phenomenon in generalized granuloma annulare.

Authors:  Kikkeri N Naveen; Varadraj V Pai; Sharatchandra B Athanikar; Gaurang Gupta; Hassan A Parshwanath
Journal:  Indian Dermatol Online J       Date:  2014-04

4.  Reverse Koebner phenomenon induced by the Mantoux test in erythrodermic psoriasis: A case report and literature review.

Authors:  Abdullah AlHargan; Marwan AlKhawajah; Mohammed AlAjlan; Ahmed AlHumidi; Rawan AlTuwaijri
Journal:  JAAD Case Rep       Date:  2018-06-14

5.  Patch granuloma annulare: clinicopathological characteristics and response to phototherapy.

Authors:  M C Aichelburg; A Pinkowicz; C Schuster; B Volc-Platzer; A Tanew
Journal:  Br J Dermatol       Date:  2019-03-13       Impact factor: 9.302

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.